Work

A Multicenter, Single-Arm, Phase I/II Dose Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Minimally-Pretreated Follicular Lymphoma

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-152126

Authors: Kirk Cahill, Michael Leukam, Theodore G. Karrison, Jessica Robertson, Justin Kline, Sonali M. Smith

Institutions: University of Chicago, University of Chicago Medical Center, University of Chicago Medicine Comprehensive Cancer Center, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3213811745

Cites:

Cited by:

Related to: 10